These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16452821)

  • 21. [Estrogens in menopause--therapy and prevention. III. Estrogen replacement in menopause: uses and risks in prevention and therapy of cardiovascular diseases].
    Reincke M; Allolio B
    Internist (Berl); 1996 Apr; 37(4):410-5; discussion 415. PubMed ID: 8655282
    [No Abstract]   [Full Text] [Related]  

  • 22. Hormone replacement therapy in climacteric and aging brain. International Menopause Society Expert Workshop, 15-18 March 2003, Pisa, Italy.
    Genazzani AR; Gambacciani M; Simoncini T; Schneider HP
    Climacteric; 2003 Sep; 6(3):188-203. PubMed ID: 14567767
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hormone treatment during the climacteric].
    Molne K; Bjoro K
    Tidsskr Nor Laegeforen; 1977 Jan; 97(2):89-93. PubMed ID: 319558
    [No Abstract]   [Full Text] [Related]  

  • 24. Postmenopausal estrogen for treatment of hot flashes: clinical applications.
    Nelson HD
    JAMA; 2004 Apr; 291(13):1621-5. PubMed ID: 15069050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hormonal treatment of climacteric complaints. A controlled, double-blind comparative study between 2 different types of sequential estrogen-gestagen preparations].
    Gam F; Helles A; Andersen B
    Ugeskr Laeger; 1977 Nov; 139(47):2808-12. PubMed ID: 339455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hormone substitution in climacteric and postmenopause. Consensus report of the Austrian Menopause Society].
    Metka M; Heytmanek G; Enzelsberger H; Kurz C; Huber J; Brandstätter N; Tscherne G; Tabarelli M; Holzer G
    Wien Med Wochenschr; 1992; 142(5-6):94-5. PubMed ID: 1615684
    [No Abstract]   [Full Text] [Related]  

  • 27. Climacteric symptoms and estrogen replacement therapy in women with endometrial carcinoma.
    Pettersson B; Adami HO; Persson I; Bergström R; Lindgren A; Johansson ED
    Acta Obstet Gynecol Scand; 1986; 65(1):81-7. PubMed ID: 3716786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormone replacement therapy for prevention in postmenopausal women: the end of controversy?].
    Balasch J
    Med Clin (Barc); 2002 Oct; 119(11):416-7. PubMed ID: 12381276
    [No Abstract]   [Full Text] [Related]  

  • 29. [Psychometric aspects of estrogen therapy in the climacteric. Quantification of the psychotropic effect of hormones in 122 women (author's transl)].
    Wenderlein JM
    MMW Munch Med Wochenschr; 1980 Mar; 122(12):419-22. PubMed ID: 6769003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protocol for estrogen replacement therapy in menopausal women.
    Ladewig PA
    Nurse Pract; 1985 Oct; 10(10):44-7. PubMed ID: 4058809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
    van de Weijer PH; Mattsson LA; Ylikorkala O
    Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy: estrogen after menopause.
    Gibaldi M
    Pharmacotherapy; 1996; 16(3):366-75. PubMed ID: 8726594
    [No Abstract]   [Full Text] [Related]  

  • 33. [Postmenopause and estrogen substitution].
    Jaszmann LJ
    Tijdschr Ziekenverpl; 1978 Sep; 31(18):822-9. PubMed ID: 250310
    [No Abstract]   [Full Text] [Related]  

  • 34. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hormone replacement in patients at high risk for thromboses].
    Hiller F
    Internist (Berl); 1997 Oct; 38(10):999-1000. PubMed ID: 9432514
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study].
    Canonico M; Scarabin PY
    Med Sci (Paris); 2008 Mar; 24(3):228-31. PubMed ID: 18334161
    [No Abstract]   [Full Text] [Related]  

  • 37. Current status of estrogen replacement therapy.
    May WJ
    Am Fam Physician; 1977 Dec; 16(6):109-13. PubMed ID: 930801
    [No Abstract]   [Full Text] [Related]  

  • 38. HRT and the surgeon. Guidelines from the Royal College of Surgeons of Edinburgh (November 1992).
    Wallace WA
    J R Coll Surg Edinb; 1993 Apr; 38(2):58-61. PubMed ID: 8478834
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dermatoses caused by estrogens and progesterone: an upcoming nosology].
    Estève E
    Ann Dermatol Venereol; 1998 Aug; 125(8):484-5. PubMed ID: 9747310
    [No Abstract]   [Full Text] [Related]  

  • 40. Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.
    Bouaziz E; Canonico M; Verstuyft C; Carcaillon L; Martin F; Scarabin PY; Guiochon-Mantel A;
    Maturitas; 2009 Oct; 64(2):136-8. PubMed ID: 19782484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.